T. May

749 total citations
57 papers, 421 citations indexed

About

T. May is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, T. May has authored 57 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 22 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in T. May's work include HIV/AIDS Research and Interventions (7 papers), Infectious Diseases and Tuberculosis (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). T. May is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), Infectious Diseases and Tuberculosis (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). T. May collaborates with scholars based in France, United States and Germany. T. May's co-authors include H. Portier, Geneviève Chêne, Patrizia Canton, Michel Daudon, Mathieu Picardeau, Michael Seidel, D. Neau, V. Vincent, Daniel Vittecoq and C. Couzigou and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

T. May

46 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. May France 11 226 191 89 59 39 57 421
Robin Dretler United States 9 231 1.0× 202 1.1× 107 1.2× 30 0.5× 19 0.5× 24 409
Elizabeth Castaño Panama 9 170 0.8× 187 1.0× 70 0.8× 33 0.6× 28 0.7× 18 454
Concha Amador Spain 10 116 0.5× 290 1.5× 43 0.5× 32 0.5× 41 1.1× 23 435
A D’Avino Italy 15 277 1.2× 144 0.8× 205 2.3× 131 2.2× 19 0.5× 31 530
David Mushatt United States 13 298 1.3× 260 1.4× 28 0.3× 24 0.4× 15 0.4× 30 559
Michelle Haas United States 12 174 0.8× 161 0.8× 56 0.6× 14 0.2× 16 0.4× 30 403
Anders Thalme Sweden 14 282 1.2× 389 2.0× 86 1.0× 62 1.1× 7 0.2× 22 604
Alice O’Donnell United Kingdom 8 652 2.9× 417 2.2× 53 0.6× 31 0.5× 26 0.7× 12 911
James Horton United States 6 332 1.5× 253 1.3× 75 0.8× 35 0.6× 10 0.3× 11 533
Jesús Gaytán-Martı́nez Mexico 10 124 0.5× 138 0.7× 72 0.8× 79 1.3× 9 0.2× 33 395

Countries citing papers authored by T. May

Since Specialization
Citations

This map shows the geographic impact of T. May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. May more than expected).

Fields of papers citing papers by T. May

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. May. The network helps show where T. May may publish in the future.

Co-authorship network of co-authors of T. May

This figure shows the co-authorship network connecting the top 25 collaborators of T. May. A scholar is included among the top collaborators of T. May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. May. T. May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morlat, Philippe, Éric Rosenthal, Sandrine Hénard, et al.. (2015). Description des causes de décès observés en France chez les personnes séropositives pour le VIH âgées de plus de 50 ans. La Revue de Médecine Interne. 36. A27–A27. 1 indexed citations
2.
3.
May, T., et al.. (2012). Antibiolor, the Lorraine antibiology network: Update on 7 years of activity. Médecine et Maladies Infectieuses. 42(8). 355–360. 3 indexed citations
4.
Doco‐Lecompte, Thanh, et al.. (2012). Relevance of fluoroquinolone use in a French teaching hospital. Médecine et Maladies Infectieuses. 42(12). 608–614. 1 indexed citations
5.
Gendrin, Vincent, et al.. (2011). Amélioration de la prescription des fluoroquinolones dans les infections urinaires. Revue de pertinence à deux tours. La Presse Médicale. 41(1). e10–e14. 4 indexed citations
6.
Doco‐Lecompte, Thanh, et al.. (2010). Revue de pertinence de la prescription des fluoroquinolones au CHU de Nancy : résultats du premier tour. Pathologie Biologie. 59(2). 122–126. 5 indexed citations
7.
Hénard, Sandrine, L. Letranchant, F. Ajana, et al.. (2010). Étude des infections à VIH nouvellement découvertes entre 2000 et 2007 dans le Nord et l’Est de la France. Médecine et Maladies Infectieuses. 40(9). 517–523. 1 indexed citations
8.
Rey, D., Bruno Hoën, P. Chavanet, et al.. (2008). High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. Journal of Antimicrobial Chemotherapy. 63(2). 380–388. 39 indexed citations
9.
Couzigou, C., Michel Daudon, J.‐L. Meynard, et al.. (2007). Urolithiasis in HIV-Positive Patients Treated with Atazanavir. Clinical Infectious Diseases. 45(8). e105–e108. 69 indexed citations
10.
Reliquet, Véronique, Clotilde Allavena, Philippe Van de Perre, et al.. (2006). Long‐term assessment of nevirapine‐containing highly active antiretroviral therapy in antiretroviral‐naive HIV‐infected patients: 3‐year follow‐up of the VIRGO study. HIV Medicine. 7(7). 431–436. 7 indexed citations
11.
Lecompte, Thibaut, et al.. (2005). Création d'un réseau ville-hôpital en antibiologie : ANTIBIOLOR. Médecine et Maladies Infectieuses. 35. S137–S139. 1 indexed citations
12.
Klossek, J.M., C. Chidiac, É. Serrano, et al.. (2005). État actuel de la prise en charge de la sinusite ou rhinosinusite maxillaire aiguë communautaire de l’adulte en France. La Presse Médicale. 34(22). 1755–1763. 5 indexed citations
13.
Duval, Xavier, Valérie Journot, C. Leport, et al.. (2004). Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor--Containing Therapy. Clinical Infectious Diseases. 39(2). 248–255. 44 indexed citations
14.
Lewden, Charlotte, Éric Jougla, Dominique Costagliola, et al.. (2004). P10-10 Comparaison de trois systèmes de recueil des cas de décès d’adultes infectés par le virus de l’immunodéficience humaine en France en 2000. Revue d Épidémiologie et de Santé Publique. 52. 127–127. 1 indexed citations
15.
Huber, Bernd, T. May, & Michael Seidel. (1998). Lamotrigine in Multihandicapped Therapy-Resistant Epileptic Patients. Clinical Drug Investigation. 16(4). 263–277. 16 indexed citations
16.
Rabaud, Christian, et al.. (1998). Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient. Journal of Infection. 36(2). 223–225. 4 indexed citations
17.
Kruppenbacher, J. P., T. May, Hans J. Eggers, & H. M. Piper. (1993). Cardiomyocytes of adult mice in long-term culture. Die Naturwissenschaften. 80(3). 132–134. 14 indexed citations
18.
Amiel, Corinne, et al.. (1992). Peripheral B cells with intracytoplasmic μ chains in HIV infection. Clinical Immunology and Immunopathology. 63(3). 275–279. 2 indexed citations
19.
Hoen, Bruno, B Aymard, A. Gérard, et al.. (1990). Sulfamethoxazole‐trimethoprim (SMZ‐TMP) as an effective therapy for Wegener's granulomatosis (WG) ‐ three more cases. Apmis. 98(S19). 65–65. 1 indexed citations
20.
May, T., A. Gérard, Guillaume Voiriot, et al.. (1986). Entérite à Campylobacter jejuni associée à un syndrome hémolytique et urémique. La Presse Médicale. 15(17). 803–804. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin Dretler Breakdown of academic impact, for papers by Elizabeth Castaño Breakdown of academic impact, for papers by Concha Amador Breakdown of academic impact, for papers by A D’Avino Breakdown of academic impact, for papers by David Mushatt Breakdown of academic impact, for papers by Michelle Haas Breakdown of academic impact, for papers by Anders Thalme Breakdown of academic impact, for papers by Alice O’Donnell Breakdown of academic impact, for papers by James Horton Breakdown of academic impact, for papers by Jesús Gaytán-Martı́nez
Rankless by CCL
2026